MapLight Therapeutics MPLT
NASDAQ MPLT
$7.44 +0.16 (+2.20%)
At close: Nov 10, 2026 · 4:00 PM EST

MapLight Therapeutics (MPLT) Capital Expenditures (2024 - 2026)

Updated

MapLight Therapeutics' Capital Expenditures came in at $376,000 for Q4 2025, up 254.7% from $106,000 a year earlier.

Analysis

MapLight Therapeutics (MPLT) Capital Expenditures (2024 - 2026) Analysis & Trends

For FY2025, MapLight Therapeutics' Capital Expenditures was $473,000, down 38.6% from FY2024.

  • Going back by year, Capital Expenditures was $770,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 1.36 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 301.00 Mn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 237.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 573.00 Mn
10 MapLight Therapeutics 340.28 Mn 340.28 Mn - 22,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22,000.00
Mar 31, 2026 24,000.00
Dec 31, 2025 376,000.00
Sep 30, 2025 31,000.00
Dec 31, 2024 106,000.00
API Access

MapLight Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=MPLT&period=max&api_key=YOUR_API_KEY